Cell Responses to IFN-gamma

NCT01317017 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Unable to isolate sufficient cells from the skin biopsy to perform study experiments.

Conditions

Plaque Psoriasis

Interventions

DRUG: Actimmune

Sponsor

Rockefeller University